Can an MRI Detect Cancer? Complete Guide

Yes, MRI can detect many types of cancer. It is one of the most useful imaging tools for finding tumours, working out their size and spread, and helping oncologists decide on treatment. MRI uses no radiation, which makes it particularly suitable for repeated scans during monitoring and follow-up.

But MRI is not a single test for all cancers. Its accuracy varies enormously depending on the body area, the type of cancer, and how the scan is performed. Some cancers show up brilliantly on MRI; others are nearly invisible. This guide covers what MRI can and cannot detect, which scans are used for which cancers, and when other tests may be more appropriate.

How MRI Detects Cancer

MRI creates detailed cross-sectional images using magnetic fields and radio waves. Cancer detection on MRI relies on several principles:

• Tissue contrast — tumours often have different water content, cellularity, and blood supply compared to normal tissue. These differences show up as abnormal signal on MRI sequences.
• Contrast enhancement — cancers tend to grow new, leaky blood vessels (angiogenesis). When gadolinium contrast is injected, tumours often light up (enhance) faster and differently than normal tissue.
• Diffusion-weighted imaging (DWI) — cancer cells are tightly packed, restricting the movement of water molecules. DWI detects this restricted diffusion and is becoming one of the most sensitive ways to spot cancer on MRI.
• Size and shape — tumours typically appear as masses with irregular borders, unlike the smooth outlines of benign cysts or normal anatomy.

Cancers That MRI Detects Well

Brain Tumours

MRI is the gold standard for brain tumour detection. It can identify tumours as small as a few millimetres and distinguish between different tumour types based on their signal characteristics. Roughly 12,000 people are diagnosed with brain tumours in the UK each year. MRI shows tumour location, size, relationship to critical brain structures, and the presence of swelling (oedema) or bleeding. Advanced techniques like MR spectroscopy and perfusion imaging help grade tumours without biopsy.

Prostate Cancer

Multiparametric MRI (mpMRI) has transformed prostate cancer diagnosis. It combines T2-weighted imaging, DWI, and contrast-enhanced sequences to detect and grade suspicious lesions using the PI-RADS scoring system (1-5). A PI-RADS 4 or 5 lesion has a high probability of clinically significant cancer. Since 2019, NICE guidelines recommend mpMRI before biopsy, which has reduced unnecessary biopsies by around 25%. Around 52,000 men are diagnosed with prostate cancer in the UK annually.

Breast Cancer

Breast MRI is the most sensitive imaging test for breast cancer, detecting around 95% of invasive cancers compared to 85% for mammography. It is used for high-risk screening (women with BRCA mutations or strong family history), assessing the extent of known cancer, checking for cancer in the opposite breast, monitoring treatment response, and evaluating breast implant integrity. Around 56,000 women are diagnosed with breast cancer in the UK each year.

Liver Cancer

MRI with liver-specific contrast agents (gadoxetate/Primovist) is the most accurate non-invasive test for detecting and characterising liver tumours. It can distinguish between hepatocellular carcinoma (HCC), metastases, benign haemangiomas, and focal nodular hyperplasia based on their contrast enhancement patterns. This is particularly valuable because liver lesions are extremely common and most are benign.

Rectal Cancer

MRI is essential for rectal cancer staging. It shows how deep the tumour invades through the rectal wall, its relationship to the mesorectal fascia (the surgical margin), and whether lymph nodes look suspicious. This information directly determines whether a patient needs pre-operative radiotherapy or chemotherapy before surgery.

Cervical and Endometrial Cancer

Pelvic MRI is the best imaging modality for staging cervical and endometrial cancers, showing depth of invasion and spread to surrounding structures.

Cancers Where MRI Has Limitations

• Lung cancer — CT is the primary tool for lung cancer detection and screening. MRI of the lungs is limited by breathing motion and air in the lungs, which produces poor signal. MRI may be used for assessing chest wall or spinal invasion by a known lung tumour, but it is not a screening tool for lung cancer.
• Bowel cancer (colon) — colonoscopy remains the gold standard for detecting colorectal polyps and cancers. MRI is used for rectal cancer staging (see above) but is not reliable for detecting small colon polyps.
• Bone cancer (primary) — MRI is excellent for showing the extent of bone tumours within the bone and surrounding soft tissues, but X-ray and CT are often better for initial characterisation of the bony changes themselves.
• Skin cancer — clinical examination and biopsy. MRI is not used for primary skin cancer detection but may be used to assess deep invasion or lymph node spread in melanoma.
• Early pancreatic cancer — small pancreatic cancers are difficult to detect on any imaging modality. CT with pancreatic protocol is currently the standard first-line investigation, though MRI and MRCP add complementary information.

Full Body MRI for Cancer Screening

Full body MRI scans have gained attention as a way to screen for cancer in people without symptoms. These scans cover the brain, spine, chest, abdomen, and pelvis in a single session and can incidentally detect tumours, aneurysms, and other abnormalities.

However, there are important considerations:

• Incidental findings are common — full body MRI frequently shows benign abnormalities (liver cysts, kidney cysts, uterine fibroids, disc bulges) that can cause unnecessary anxiety and lead to further investigations.
• Not all cancers are detectable — lung cancer, bowel cancer, and very early-stage cancers may still be missed.
• No screening programme recommends it yet — there is currently no evidence from randomised trials that full body MRI screening reduces cancer deaths in the general population.
• It can still be valuable — for people with strong cancer family history, known genetic predisposition, or high anxiety about cancer, a full body MRI can provide meaningful information and detect significant abnormalities early.

What to Expect During a Cancer-Related MRI

The experience depends on which body area is being scanned:

• Duration — typically 30-60 minutes. Prostate mpMRI and breast MRI tend to be on the longer side.
• Contrast — most cancer-related MRIs require gadolinium contrast injection (a small cannula in your arm). You may feel a brief cool sensation as it is injected. Serious reactions are very rare (around 1 in 40,000).
• Positioning — varies by scan. Brain: on your back. Breast: face down with your breasts hanging into cushioned apertures. Prostate: on your back, sometimes with an endorectal coil (though many centres now use external coils only).
• Noise — standard MRI knocking and buzzing. Headphones or earplugs provided.

Preparation

For most cancer MRIs, you will need a recent kidney function blood test (eGFR) because contrast is usually required. You may be asked to fast for 4-6 hours beforehand, especially for liver and abdominal scans. Specific preparation varies — your booking team will advise.

When NOT to Use MRI for Cancer Detection

• Lung cancer screening — low-dose CT is the proven screening tool for high-risk patients (heavy smokers over 55).
• Bowel cancer screening — colonoscopy, FIT (faecal immunochemical test), or CT colonography are the right tools.
• Thyroid nodules — ultrasound is the first-line investigation, not MRI.
• General "cancer worry" without specific symptoms — speak to your GP first. Targeted testing based on your symptoms, age, and risk factors is more effective than blanket scanning.

Alternative and Complementary Cancer Tests

• CT scan — better for lungs, bone detail, and initial staging of many cancers. Uses radiation but is faster than MRI.
• PET-CT — combines metabolic and structural information. The gold standard for staging lymphoma, assessing cancer spread, and monitoring treatment response. Not widely available privately.
• Ultrasound — first-line for thyroid, testicular, and some liver/kidney assessments. No radiation, portable, cheap.
• Mammography — standard breast cancer screening (NHS programme: every 3 years, ages 50-71).
• Blood biomarkers — PSA (prostate), CA-125 (ovarian), CEA (bowel), AFP (liver). These are not diagnostic on their own but can indicate the need for imaging.

What Happens After a Cancer is Found on MRI

• MDT discussion — your case will be discussed at a multidisciplinary team meeting involving radiologists, oncologists, surgeons, and specialist nurses.
• Biopsy — most cancers need a tissue sample to confirm the type and grade. MRI-guided biopsies can be performed for some locations (breast, prostate, liver).
• Staging scans — additional imaging (CT chest/abdomen/pelvis, PET-CT, bone scan) to check for spread.
• Treatment planning — surgery, radiotherapy, chemotherapy, immunotherapy, or a combination. The specific pathway depends on cancer type, stage, and your overall health.
• 2-week wait referral — in the UK, if cancer is suspected, you should be seen by a specialist within 2 weeks under the urgent cancer referral pathway.

UK Cancer Statistics

• Around 375,000 new cancer cases are diagnosed in the UK each year
• 1 in 2 people will develop cancer in their lifetime
• The most common cancers in the UK are breast, prostate, lung, and bowel — together accounting for over half of all new cases
• Early detection significantly improves survival — for example, stage 1 breast cancer has a 98% five-year survival rate vs 26% for stage 4
• The NHS Long Term Plan aims to diagnose 75% of cancers at stage 1 or 2 by 2028

Frequently Asked Questions

Related Articles

• Prostate Cancer MRI
• MRI Scan for Brain Tumours
• Breast Cancer MRI
• Fatty Liver Disease MRI
• Ovarian Cyst MRI